Clinical Trial Update: Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study evaluating oral senicapoc in subjects with atopic asthma undergoing allergen challenge has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Asthma

Drugs mentioned

• Senicapoc (senicapoc)

Snippet

Sponsor: Icagen | Conditions: Atopic Asthma | Phase 2 | Status: COMPLETED